Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology

Area of Science:

• Oncology
• Clinical Practice Guidelines

Background:

• Non-Small Cell Lung Cancer (NSCLC) treatment requires up-to-date recommendations.
• The NCCN Guidelines provide evidence-based treatment strategies for NSCLC patients.

Purpose of the Study:

• To present the latest NCCN Guidelines for NSCLC treatment.
• To highlight updated targeted therapy recommendations for advanced or metastatic NSCLC with actionable biomarkers.

Main Methods:

• Review of recent FDA approvals.
• Analysis of current clinical data.
• Expert panel consensus on treatment recommendations.

Main Results:

• Updated list of recommended targeted therapies for NSCLC.
• Focus on advanced or metastatic disease.
• Inclusion of therapies for actionable biomarkers.

Conclusions:

• The NCCN Guidelines provide current treatment standards for NSCLC.
• Updated recommendations ensure optimal use of targeted therapies.
• Guideline adherence can improve outcomes for NSCLC patients with actionable biomarkers.